National Institutes of Health, National Cancer Institute, Division of Extramural Activities - Home Page
NIH NCI DEA Logo NIH NCI NCI/DEA
Active NCI RFAs: FY 2021 FY 2020 FY 2019 |ArchiveRFAs |ActivePAs
Current and Recent Requests for Applications (RFA's)
RFA's that are active or have expired within the last 3 months (and associated notices)
2021 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
DA21-009Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional)EXPIRED-OCT 20, 2020
HD21-002Centers to Advance Research in Endometriosis (CARE) (P01 Clinical Trial Not Allowed)ACTIVE-DEC 01, 2020
2020Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
CA20-054Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed)ACTIVE-JAN 16, 2021
CA20-053Genomic Data Analysis Network: Genomic Data Analysis Center (U24 Clinical Trial Not Allowed)ACTIVE-NOV 13, 2020
CA20-052Limited Competition: Childhood Cancer Survivor Study (U24 Clinical Trial Required)ACTIVE-NOV 19, 2020
CA20-051Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)ACTIVE-JAN 19, 2022
CA20-050New Cohorts for Environmental Exposures and Cancer Risk (CEECR) Coordinating Center (U24 Clinical Trial Not Allowed)ACTIVE-JAN 30, 2021
CA20-049New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed)ACTIVE-JAN 30, 2021
CA20-048The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)ACTIVE-NOV 19, 2020
CA20-047Glioblastoma Therapeutics Network (U19 Clinical Trial Required)ACTIVE-NOV 20, 2020
CA20-046Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)ACTIVE-DEC 15, 2021
CA20-045Limited Competition: International Agency for Research on Cancer (IARC) Monographs Program (R01 Clinical Trial Not Allowed)ACTIVE-DEC 17, 2020
CA20-044Visualization Methods and Tools Development for Enhancing Cancer Moonshot Data (R33 Clinical Trial Not Allowed)ACTIVE-OCT 31, 2020
CA20-043Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed)ACTIVE-JAN 21, 2021
CA20-0423D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)ACTIVE-NOV 10, 2020
CA20-041NCI Pediatric In Vivo Testing Program Coordinating Center (U24 Clinical Trial Not Allowed)ACTIVE-NOV 10, 2020
CA20-040Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)ACTIVE-FEB 18, 2021
CA20-039Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)EXPIRED-JUL 23, 2020
CA20-038Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional)EXPIRED-JUL 23, 2020
CA20-037Tobacco Use and HIV in Low and Middle-Income Countries (U01 Clinical Trial Optional)EXPIRED-SEP 25, 2020
CA20-036Improving Smoking Cessation Interventions among People Living with HIV (R21 Clinical Trial Optional)EXPIRED-SEP 05, 2020
CA20-035Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Trial Optional)EXPIRED-SEP 05, 2020
CA20-034NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed)ACTIVE-NOV 10, 2020
CA20-033SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)EXPIRED-SEP 01, 2020
CA20-031Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)ACTIVE-JUN 25, 2021
CA20-029Metastasis Research Network (U54 Clinical Trial Not Allowed)ACTIVE-MAY 29, 2021
CA20-028Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)ACTIVE-JUL 31, 2021
CA20-027Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional)ACTIVE-JUL 31, 2021
CA20-026Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)EXPIRED-SEP 30, 2020
CA20-025Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)EXPIRED-SEP 30, 2020
CA20-024Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)EXPIRED-SEP 30, 2020
CA20-023Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)EXPIRED-SEP 30, 2020
CA20-022Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)EXPIRED-SEP 30, 2020
CA20-021Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)EXPIRED-SEP 30, 2020
CA20-020Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)EXPIRED-SEP 30, 2020
CA20-019Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)EXPIRED-SEP 30, 2020
CA20-018Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)EXPIRED-SEP 30, 2020
CA20-017Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)EXPIRED-SEP 30, 2020
CA20-013Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)ACTIVE-NOV 19, 2020
CA20-012Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)ACTIVE-NOV 19, 2020
CA20-011Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)ACTIVE-NOV 19, 2020
CA20-010Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)ACTIVE-NOV 19, 2020
CA20-009Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)ACTIVE-NOV 19, 2020
CA20-008Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)ACTIVE-NOV 19, 2020
CA20-007Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)ACTIVE-NOV 19, 2020
CA20-005Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)ACTIVE-NOV 18, 2020
CA20-004Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)ACTIVE-NOV 18, 2020
2020 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
AI20-023Limited Competition: International Epidemiology Databases to Evaluate AIDS (IeDEA) (U01 Clinical Trial Not Allowed)EXPIRED-AUG 05, 2020
DK20-502Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Biostatistics Research Center (BRC) (Collaborative U01 Clinical Trial Required)EXPIRED-JUL 23, 2020
DK20-501Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers (Collaborative U01 Clinical Trial Required)EXPIRED-JUL 23, 2020
ES20-018Utilizing In Vitro Functional Genomics Advances for Gene-Environment (G x E) Discovery and Validation (R01 Clinical Trial Not Allowed)ACTIVE-FEB 02, 2021
HG20-048Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01, Clinical Trial Optional)ACTIVE-JUL 09, 2021
HL20-006Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)ACTIVE-JAN 15, 2022
NS20-011HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)ACTIVE-SEP 09, 2022
NS20-010HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)ACTIVE-SEP 09, 2022
NS20-009HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)ACTIVE-SEP 09, 2022
NS20-008HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)ACTIVE-SEP 09, 2022
OD20-018Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)EXPIRED-SEP 19, 2020
OD20-014Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed)EXPIRED-SEP 16, 2020
OD20-013Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)EXPIRED-AUG 08, 2020
OD20-011Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)ACTIVE-JUL 11, 2022
OD20-010Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)ACTIVE-JUL 11, 2022
OD20-009Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)ACTIVE-JUL 11, 2022
OD20-008Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)ACTIVE-JUL 11, 2022
2019Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
CA19-053Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed)ACTIVE-JUN 24, 2021
CA19-052Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed)ACTIVE-JUN 24, 2021
CA19-051Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed)ACTIVE-JUN 24, 2021
CA19-050Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed)ACTIVE-JUN 24, 2021
CA19-049Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed)ACTIVE-JUN 24, 2021
CA19-045Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional)ACTIVE-OCT 31, 2020
CA19-034Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional)EXPIRED-OCT 19, 2020
CA19-032Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)EXPIRED-AUG 04, 2020
2019 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
OD19-028Tobacco Regulatory Science (R01 Clinical Trial Optional)ACTIVE-FEB 14, 2021
OD19-022Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)ACTIVE-MAR 09, 2021
OD19-021Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed)ACTIVE-MAR 09, 2021